Drug Trial Radar · NCT07236372
Comparing Standard-Dose and High-Dose Cetirizine for Acute Urticaria
Last checked: Nov 20, 2026Latest source record: Oct 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
140
Planned (sponsor's estimate)
Start
Nov 15, 2025
Primary completion
Mar 2027
Study completion Oct 2027
Sponsor
- Lead sponsor
- University of PhayaoAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Nov 19, 2025
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 60 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this clinical trial is to learn whether a higher dose of cetirizine works better than the standard dose to relieve symptoms of acute urticaria (hives) in adults. The study also aims to learn about the safety of taking a higher dose for a short period of time. The main questions the study aims to answer are: 1. Does the higher dose of cetirizine help people with acute urticaria improve faster than the standard dose? 2. What side effects do participants experience when taking the higher dose? Researchers will compare two groups: one group taking the standard dose of cetirizine (10 mg per day) and another group taking a higher dose (40 mg per day). This will help researchers understand which dose works better and whether the higher dose is safe. Participants will: Take the assigned study medication for 7 days Record their daily symptoms, including itch and hive severity Return for follow-up visits on Day 3, Day 7, and Week 6 Have blood tests to check liver and kidney function before and after treatment This study may help improve treatment options for people with acute urticaria and reduce the need for unnecessary steroid use.
Conditions
- Acute Urticaria
Interventions
Cetirizine 10 mg once dailyDrug
Participants in the standard-dose arm receive cetirizine 10 mg orally once daily for 7 days. The study medication is provided in capsule form to match the appearance of the high-dose capsules.
Cetirizine 20 mg twice daily, total 40 mg/dayDrug
Participants in the high-dose arm receive cetirizine 20 mg orally twice daily (total 40 mg/day) for 7 days. The study medication is provided in capsule form to ensure identical appearance between arms.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to Resolution of Acute Urticaria SymptomsTime frame: From Day 0 (first dose) to Day 7 or until complete symptom resolution, whichever occurs first.
- Change in Urticaria Activity Score From BaselineTime frame: Baseline to Day 7
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University of Phayao Hospital
Phayao, Mueang, Thailand · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.